[Federal Register Volume 82, Number 20 (Wednesday, February 1, 2017)]
[Notices]
[Pages 8959-8960]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2017-02074]
-----------------------------------------------------------------------
NUCLEAR REGULATORY COMMISSION
[NRC-2017-0013]
Information Collection: 10 CFR Part 35, ``Medical Use of
Byproduct Material''
AGENCY: Nuclear Regulatory Commission.
ACTION: Renewal of existing information collection; request for
comment.
-----------------------------------------------------------------------
SUMMARY: The U.S. Nuclear Regulatory Commission (NRC) invites public
comment on the renewal of Office of Management and Budget (OMB)
approval for an existing collection of information. The information
collection is entitled, 10 CFR part 35, ``Medical Use of Byproduct
Material.''
DATES: Submit comments by April 3, 2017. Comments received after this
date will be considered if it is practical to do so, but the Commission
is able to ensure consideration only for comments received on or before
this date.
ADDRESSES: You may submit comments by any of the following methods:
Federal Rulemaking Web site: Go to http://www.regulations.gov and search for Docket ID NRC-2017-0013. Address
questions about NRC dockets to Carol Gallagher; telephone: 301-415-
3463; email: [email protected]. For technical questions, contact
the individual listed in the FOR FURTHER INFORMATION CONTACT section of
this document.
Mail comments to: David Cullison, Office of the Chief
Information Officer, Mail Stop: T-5 F53, U.S. Nuclear Regulatory
Commission, Washington, DC 20555-0001.
For additional direction on obtaining information and submitting
comments, see ``Obtaining Information and Submitting Comments'' in the
SUPPLEMENTARY INFORMATION section of this document.
FOR FURTHER INFORMATION CONTACT: David Cullison, Office of the Chief
Information Officer, U.S. Nuclear Regulatory Commission, Washington, DC
20555-0001; telephone: 301-415-2084; email:
[email protected].
SUPPLEMENTARY INFORMATION:
I. Obtaining Information and Submitting Comments
A. Obtaining Information
Please refer to Docket ID NRC-2017- 0013 when contacting the NRC
about the availability of information for this action. You may obtain
publicly-available information related to this action by any of the
following methods:
Federal Rulemaking Web site: Go to http://www.regulations.gov and search for Docket ID NRC-2017-0013.
NRC's Agencywide Documents Access and Management System
(ADAMS): You may obtain publicly-available documents online in the
ADAMS Public Documents collection at http://www.nrc.gov/reading-rm/adams.html. To begin the search, select ``ADAMS Public Documents'' and
then select ``Begin Web-based ADAMS Search.'' For problems with ADAMS,
please contact the NRC's Public Document Room (PDR) reference staff at
1-800-397-4209, 301-415-4737, or by email to [email protected]. The
supporting statement is available in ADAMS under Accession No.
ML16333A028.
NRC's PDR: You may examine and purchase copies of public
documents at the NRC's PDR, Room O1-F21, One White Flint North, 11555
Rockville Pike, Rockville, Maryland 20852.
NRC's Clearance Officer: A copy of the collection of
information and related
[[Page 8960]]
instructions may be obtained without charge by contacting NRC's
Clearance Officer, David Cullison, Office of the Chief Information
Officer, U.S. Nuclear Regulatory Commission, Washington, DC 20555-0001;
telephone: 301-415-2084; email: [email protected].
B. Submitting Comments
Please include Docket ID NRC-2017-0013 in the subject line of your
comment submission, in order to ensure that the NRC is able to make
your comment submission available to the public in this docket.
The NRC cautions you not to include identifying or contact
information in comment submissions that you do not want to be publicly
disclosed in your comment submission. The NRC will post all comment
submissions at http://www.regulations.gov as well as enter the comment
submissions into ADAMS, and the NRC does not routinely edit comment
submissions to remove identifying or contact information.
If you are requesting or aggregating comments from other persons
for submission to the NRC, then you should inform those persons not to
include identifying or contact information that they do not want to be
publicly disclosed in their comment submission. Your request should
state that the NRC does not routinely edit comment submissions to
remove such information before making the comment submissions available
to the public or entering the comment into ADAMS.
II. Background
In accordance with the Paperwork Reduction Act of 1995 (44 U.S.C.
Chapter 35), the NRC is requesting public comment on its intention to
request the OMB's approval for the information collection summarized
below.
1. The title of the information collection: 10 CFR part 35,
``Medical Use of Byproduct Material.''
2. OMB approval number: 3150-0010
3. Type of submission: Extension
4. The form number, if applicable: N/A
5. How often the collection is required or requested: Reports of
medical events, doses to an embryo/fetus or nursing child, or leaking
source are reportable on occurrence. A specialty board certifying
entity desiring to be recognized by the NRC must submit a one-time
request for recognition and infrequently revise the information.
6. Who will be required or asked to respond: Physicians and medical
institutions holding an NRC license authorizing the administration of
byproduct material or radiation from this material to humans for
medical use. A specialty board certification entity desiring to have
its certifying process and board certificate recognized by NRC.
7. The estimated number of annual responses: 276,359 ((NRC: 36,313
+ 962 recordkeepers = 37,275) + (Agreement States: 232,925 + 6,157
recordkeepers + 2 specialty certification entity = 239,084)).
8. The estimated number of annual respondents: 7,121(NRC: 962 +
Agreement states 6,157+ 2 specialty certification entities).
9. The estimated number of hours needed annually to comply with the
information collection requirement or request: 1,073,224 hours (NRC
Licensees 145,195 hrs + Agreement States 928,027 hrs + specialty
certifying entities 2 hrs).
10. Abstract: 10 CFR part 35, ``Medical Use of Byproduct
Material,'' contains NRC's requirements and provisions for the medical
use of byproduct material and for issuance of specific licenses
authorizing the medical use of this material. These requirements and
provisions provide for the radiation safety of workers, the general
public, patients, and human research subjects. Part 35 contains
mandatory requirements that apply to NRC licensees authorized to
administer byproduct material or radiation therefrom to humans for
medical use. These requirements also provide voluntary provisions for
specialty boards to apply to have their certification processes
recognized by the NRC so that their board certified individuals can use
the certifications as proof of training and experience.
III. Specific Requests for Comments
The NRC is seeking comments that address the following questions:
1. Is the proposed collection of information necessary for the NRC
to properly perform its functions? Does the information have practical
utility?
2. Is the estimate of the burden of the information collection
accurate?
3. Is there a way to enhance the quality, utility, and clarity of
the information to be collected?
4. How can the burden of the information collection on respondents
be minimized, including the use of automated collection techniques or
other forms of information technology?
Dated at Rockville, Maryland, this 26th day of January 2017.
For the Nuclear Regulatory Commission.
David Cullison,
NRC Clearance Officer.
[FR Doc. 2017-02074 Filed 1-31-17; 8:45 am]
BILLING CODE 7590-01-P